Moolec Science SA
Moolec Science SA is a science-based food ingredient company focused on developing functional ingredients through molecular farming and precision fermentation. Moolec Science SA creates ingredients for food, pet food, animal feed, and dietary supplements by engineering crops such as soy and safflower, as well as using microbial systems, to produce animal-like proteins, nutritional oils, and other bioactive compounds. Its current product portfolio includes textured soy proteins, safflower-derived oil, meat replacement ingredients, and protein-based formulations designed for use in plant-based and hybrid food applications. The company operates an integrated platform that combines research and development, manufacturing, and regulatory capabilities to support product validation and commercialization across multiple markets. Moolec Science SA serves the alternative protein and specialty ingredients segments of the food industry, where it aims to provide ingredients with animal-like functionality while using plant-based production systems.
$1.72
+$0.03 (+2.08%)
EOD Oct 23, 2026
The business is unprofitable at the operating level (-1.05% margin). The case rests on reaching sustained profitability.
Revenue declined 28.5% in the fiscal year ended Jun 2025. Margins deteriorated 10.0pp alongside, both lines moving the wrong way.
Free cash flow declined 176% in the fiscal year ended Jun 2025 versus the year before, cash generation momentum has weakened. ROIC fell 9.8 points in the fiscal year ended Jun 2025, capital efficiency is deteriorating.
Price History
Valuation & Multiples
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$334M
▼ -28.5% YoY
Net Income (TTM)
-$177M
▼ -507.8% YoY
Op. Margin
-1.05%
▼ -10.0pp YoY
ROIC
-0.58%
▼ -9.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$11M
▼ -175.6% YoY
Op. Cash Flow (TTM)
$4M
▼ -90.8% YoY
Net Debt
$238M
Cash & Equiv.
$9M
Continue Research
Is Moolec Science SA (MLEC) overvalued?
Moolec Science SA (MLEC)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Moolec Science SA scores 10/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from company filings; read the full methodology, or see how the market compares in our US profitability statistics. This is analysis, not investment advice.
Frequently asked
Is Moolec Science SA a high-quality business?+
Moolec Science SA scores 10 out of 100 on Intrinsiqq's quality score, a weighted blend of 4 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -1.1% operating margin and a -0.6% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from company filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Is Moolec Science SA a good stock to buy right now?+
That depends on valuation and quality together, not either alone. you should weigh MLEC's valuation and scores 10/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from company filings, not investment advice.
Related stocks: Biotechnology
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing MLEC
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.